Polymorphisms in interleukin 17A gene and coal workers’ pneumoconiosis risk in a Chinese population

BMC Pulmonary Medicine

Chunhui Ni¹  Baoli Zhu²  Jingjin Yang¹  Lei Han¹  Ting Wang¹  Baiqun Wu¹  Xiaoming Ji¹  Ruhui Han¹ 

[1] Department of Occupational Medicine and Environmental Health, School of Public Health, Nanjing Medical University, Nanjing 210029, China;Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China

关键词: Coal workers’ pneumoconiosis;    Polymorphisms;    IL-17A;    Genetics;   

Others  :  1222568
DOI  :  10.1186/s12890-015-0076-1

 received in 2015-01-14, accepted in 2015-07-20,  发布年份 2015

【 摘 要 】

Background

The interleukin 17A (IL-17A) which is located on chromosome 6p and has been linked to chronic inflammation, is an important candidate gene conferring coal workers’ pneumoconiosis (CWP). The purpose of this study was to investigate the genetic association between single nucleotide polymorphisms (SNPs) of IL-17A and CWP in a Chinese population.

Methods

We conducted a case–control study to investigate the role of four common SNPs in the IL-17A gene, and evaluated the relationship between these four SNPs and dust-exposure year, tobacco smoking and stages of CWP. A total of 1391 subjects was enrolled in this study, including 694 subjects in control group and 697 in case group. TaqMan based qRT-PCRs were taken to genotype rs2275913, rs3748067, rs4711998, and rs8193036 within the IL-17A gene. Luciferase assays were used to determine the effects of rs8193036 C > T alleles on the expression of IL-17A.

Results

Unconditional logistic regression analysis showed that the genotypes of rs3748067 AA (adjusted OR = 0.43, 95 % CI = 0.23–0.83) and rs8193036 TT (adjusted OR = 0.59, 95 % CI = 0.40–0.86) were associated with a decreased risk of CWP, particularly among subgroups of smokers (adjusted OR =0.34, 95 % CI = 0.13–0.86 for rs3748076; adjusted OR = 0.41, 95 % CI = 0.23–0.71 for 8193036) and CWP cases with stage I (adjusted OR = 0.45, 95 % CI = 0.21–0.98 for rs3748076; adjusted OR = 0.46, 95 % CI = 0.28–0.74 for 8193036). Furthermore, the polymorphism of rs3748067 significantly reduced the CWP risk among cases with over 27 years of dust exposure (adjusted OR = 0.42, 95 % CI = 0.18–0.97). The luciferase assays in two cell lines showed that the rs8193036 C > T substitution could reduce the expression of IL-17A, which was consistent with the findings of our association study.

Conclusions

The rs3748067 G > A and rs8193036 C > T polymorphisms decrease CWP risk. These findings could be helpful in identifying individuals at decreased risk for CWP and further studies are warranted to validate them.

【 授权许可】

   
2015 Han et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Pneumoconiosis and advanced occupational lung disease among surface coal miners — 16 States, 2010–2011. MMWR Morb Mortal Wkly Rep. 2012; 61(23):431-4.
• [2]McCunney RJ, Morfeld P, Payne S. What component of coal causes coal workers’ pneumoconiosis? J Occup Environ Med. 2009; 51(4):462-71.
• [3]Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol. 2004; 4(8):583-94.
• [4]Ates I, Suzen HS, Yucesoy B, Tekin IO, Karakaya A. Association of cytokine gene polymorphisms in CWP and its severity in Turkish coal workers. Am J Ind Med. 2008; 51(10):741-7.
• [5]Soutar CA. Dust concentrations and respiratory risks in coalminers: key risk estimates from the British Pneumoconiosis Field Research. Occup Environ Med. 2004; 61(6):477-81.
• [6]Cohen RA. Is the increasing prevalence and severity of coal workers’ pneumoconiosis in the United States due to increasing silica exposure? Occup Environ Med. 2010; 67(10):649-50.
• [7]Weston A. Work-related lung diseases. IARC Sci Publ. 2011; 163:387-405.
• [8]Brodlie M, McKean MC, Johnson GE, Anderson AE, Hilkens CM, Fisher AJ et al.. Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur Respir J. 2011; 37(6):1378-85.
• [9]Okamoto Y, Hasegawa M, Matsushita T, Hamaguchi Y, Huu DL, Iwakura Y et al.. Potential roles of interleukin-17A in the development of skin fibrosis in mice. Arthritis Rheum. 2012; 64(11):3726-35.
• [10]Pridgeon C, Bugeon L, Donnelly L, Straschil U, Tudhope SJ, Fenwick P et al.. Regulation of IL-17 in chronic inflammation in the human lung. Clin Sci. 2011; 120(12):515-24.
• [11]Song LY, Weng D, Liu FW, Chen Y, Li CY, Dong L et al.. Tregs Promote the Differentiation of Th17 Cells in Silica-Induced Lung Fibrosis in Mice. PLoS One. 2012; 7(5):e37286.
• [12]Aujla SJ, Dubin PJ, Kolls JK. Interleukin-17 in pulmonary host defense. Exp Lung Res. 2007; 33(10):507-18.
• [13]Glader P, Smith ME, Malmhall C, Balder B, Sjostrand M, Qvarfordt I et al.. Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin. The European Respir J. 2010; 36(5):1155-64.
• [14]Simonian PL, Roark CL, Born WK, O’Brien RL, Fontenot AP. γδ T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis. Transl Res. 2009; 154(5):222-7.
• [15]Roark CL, Simonian PL, Fontenot AP, Born WK, O’Brien RL. gammadelta T cells: an important source of IL-17. Curr Opin Immunol. 2008; 20(3):353-7.
• [16]Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, Cheever AW et al.. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. The J Exp Med. 2010; 207(3):535-52.
• [17]Mi S, Li Z, Yang HZ, Liu H, Wang JP, Ma YG et al.. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol. 2011; 187(6):3003-14.
• [18]Chen Y, Li C, Weng D, Song L, Tang W, Dai W et al.. Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice. Toxicol Appl Pharmacol. 2014; 275(1):62-72.
• [19]Wang JY, Shyur SD, Wang WH, Liou YH, Lin CG, Wu YJ et al.. The polymorphisms of interleukin 17A (IL17A) gene and its association with pediatric asthma in Taiwanese population. Allergy. 2009; 64(7):1056-60.
• [20]Wang S, Zhai H, Su Y, Wang Y. IL-17 F but not IL-17A gene polymorphism confers risk to multiple sclerosis in a Chinese Han population. J Neurol Sci. 2014; 342(1–2):133-6.
• [21]Zhang X, Zheng L, Sun Y, Zhang X. Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population. Tumour Biol. 2014; 35(2):1575-80.
• [22]Peng Y, Zhou B, Wang YY, Shi S, Zhang K, Zhang L et al.. Analysis of IL-17 gene polymorphisms in Chinese patients with dilated cardiomyopathy. Hum Immunol. 2013; 74(5):635-9.
• [23]Wang M, Ye Y, Qian H, Song Z, Jia X, Zhang Z et al.. Common genetic variants in pre-microRNAs are associated with risk of coal. J Hum Genet. 2010; 55(1):13-7.
• [24]Wang M, Wang S, Song Z, Ji X, Zhang Z, Zhou J et al.. Associations of IL-4, IL-4R, and IL-13 gene polymorphisms in coal workers’ pneumoconiosis in China: a case–control study. PLoS One. 2011; 6(8): Article ID e22624
• [25]Kaminski N, Chen W, Liu Y, Wang H, Hnizdo E, Sun Y et al.. Long-Term Exposure to Silica Dust and Risk of Total and Cause-Specific Mortality in Chinese Workers: A Cohort Study. PLoS Med. 2012; 9(4): Article ID e1001206
• [26]Moran EM, Mastaglia FL. The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications. Neuromuscul Disord. 2014; 24(11):943-52.
• [27]Dong Z, Kang Q, Lei W, Zhong H, Tai W, Wang D. Effects of interleukin-17 on murine pulmonary fibroblast proliferation, transformation and collagen synthesis. Nan Fang Yi Ke Da Xue Xue Bao. 2012; 32(1):75-9.
• [28]Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med. 2011; 184(2):252-8.
• [29]Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D et al.. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology. 2012; 143(3):765-76.
• [30]Gasse P, Riteau N, Vacher R, Michel ML, Fautrel A, di Padova F et al.. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS One. 2011; 6(8): Article ID e23185
• [31]Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T et al.. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol. 2012; 188(8):3573-83.
• [32]Biancheri P, Pender SL, Ammoscato F, Giuffrida P, Sampietro G, Ardizzone S et al.. The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis. Fibrogenesis & Tissue Repair. 2013; 6(1):13. BioMed Central Full Text
• [33]Gunthner R, Kumar VR, Lorenz G, Anders HJ, Lech M. Pattern-recognition receptor signaling regulator mRNA expression in humans and mice, and in transient inflammation or progressive fibrosis. Int J Mol Sci. 2013; 14(9):18124-47.